GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (OTCPK:BIOYF) » Definitions » Accounts Receivable

BIOYF (Biosyent) Accounts Receivable : $2.87 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Biosyent Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Biosyent's accounts receivables for the quarter that ended in Sep. 2024 was $2.87 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Biosyent's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 37.15.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Biosyent's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was $0.94.


Biosyent Accounts Receivable Historical Data

The historical data trend for Biosyent's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Accounts Receivable Chart

Biosyent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.25 1.95 2.05 2.09

Biosyent Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 2.09 1.47 3.63 2.87

Biosyent Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Biosyent Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Biosyent's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.872/7.054*91
=37.15

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Biosyent's accounts receivable are only considered to be worth 75% of book value:

Biosyent's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(12.598+0.75 * 2.872+0.5 * 4.178-5.997
-0-0)/11.5939
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Biosyent Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Biosyent's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyent Business Description

Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Biosyent Headlines

From GuruFocus

Q2 2020 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2021 Biosyent Inc Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

BioSyent Announces Grant of Restricted Share Units

By GlobeNewswire GlobeNewswire 03-31-2023

Q2 2022 Biosyent Inc Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

BioSyent Initiates First Dividend

By GlobeNewswire GlobeNewswire 10-12-2022

Q3 2020 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

BioSyent Schedules Q2 and H1 2022 Earnings Release for August 23, 2022

By GlobeNewswire GlobeNewswire 08-17-2022

Q3 2021 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2020 Biosyent Inc Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

BioSyent Announces Approval of New Product

By GlobeNewswire GlobeNewswire 05-31-2023